SEC Form 4 · accession 0002024911-26-000006
BIO-RAD LABORATORIES, INC. · BIO BIO.B
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eva Anette Engelhardt
Officer — EVP, President, CDG
Period of report
Sep 4, 2026
Accepted (ET)
Sep 9, 2026 · 6:45 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000012208
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Bio-Rad A Common StockF1 | Sep 5, 2026 | M | 1,027 | $0.00 | A | 1,530 | D | |
| Bio-Rad A Common Stock | Sep 5, 2026 | F | 369 | $386.11 | D | 1,161 | D | |
| Bio-Rad A Common StockF1 | Sep 6, 2026 | M | 1,152 | $0.00 | A | 2,313 | D | |
| Bio-Rad A Common Stock | Sep 6, 2026 | F | 485 | $386.11 | D | 1,828 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2,F3 | $0.00 | Sep 4, 2026 | A | 4,313 | A | — | — | Bio-Rad A Common Stock | 4,313 | 4,313 | D |
| Restricted Stock UnitsF2,F4 | $0.00 | Sep 5, 2026 | M | 1,027 | D | — | — | Bio-Rad A Common Stock | 1,027 | 3,083 | D |
| Restricted Stock UnitsF2,F4 | $0.00 | Sep 6, 2026 | M | 1,152 | D | — | — | Bio-Rad A Common Stock | 1,152 | 2,304 | D |
Explanation of responses
- F1Shares of Class A common stock acquired on the vesting of restricted stock units.
- F2Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
- F3The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter.
- F4The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.